by Colin Kenny, GP, Dromore
People with type 2 diabetes are at greater risk of cognitive decline in later life. Investigators used data from 831 participants in the Edinburgh Type 2 Diabetes Study (ET2DS) to test the associations of serum cholesterol, blood pressure, glycaemic control and smoking with late-life cognitive decline.
They concluded that smoking history, long-term exposure to raised blood pressure and poorer glycaemic control were independently associated with an accelerated late-life cognitive decline, short of dementia. The study provided strong observational evidence that smoking history, higher blood pressure and poorer glycaemic control are independently associated with accelerated late-life cognitive decline in people with type 2 diabetes.
To access the full publication, click here
